Clinical Trial Update: An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer

View source ↗

Summary

An observational study evaluating capecitabine (Xeloda) in participants with metastatic or advanced breast cancer has been completed. The results of the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2016-08-12